文献速递技术与安全CTMRUS

成人血管内给予对比剂后的急性非过敏反应

Acute non-hypersensitivity adverse reactions following intravascular administration of contrast agents in adult patients.
PubMed 文献 · Eur J Radiol · 2025-08-06

本文回顾成人血管内给予对比剂后急性A型(毒性/生理性)不良反应,指出碘对比剂和钆对比剂后此类反应相对少见、超声对比剂后罕见,多为短暂轻度,恶心呕吐最常见,机制为化学毒性和/或高渗性。作者提出将急性非过敏反应、迟发A型反应与B型(过敏)反应三分类,以利于准确评估和报告。

要点

  • 急性A型反应多为短暂轻度,恶心呕吐最常见,通常仅需对症支持。
  • 碘对比剂和钆对比剂后A型反应相对少见,超声对比剂后罕见。
  • 作者提出三分类:急性非过敏反应、迟发A型反应、B型过敏反应。

核心结论

  • 急性A型反应多为化学毒性和/或高渗性所致,多数短暂轻度,恶心呕吐最常见,轻中度对症支持,重度需专科治疗。
  • 作者建议将对比剂不良反应分为急性非过敏反应、迟发A型反应和B型(过敏)反应三类,以促进准确评估和报告。

研究设计与样本

  • 本文为对成人血管内给予对比剂后急性A型不良反应及非特异性反应(美国放射学会分类中标注为「生理性」)的批判性综述,并提出三分类建议。

诊断标准与关键数值

  • 历史分类将对比剂急性药物不良反应分为A型(毒性/生理性)和B型(过敏)反应。
  • 作者提出分为急性非过敏反应、迟发A型反应和B型(过敏)反应三类。

临床应用与阅片要点

  • 阅片和报告时可按作者提出的三分类区分急性非过敏反应、迟发A型反应与B型过敏反应,以利准确评估和报告。
  • 恶心呕吐是各类对比剂中最常报告的A型反应,多由化学毒性和/或高渗性所致。
  • 轻中度A型反应通常对症支持,重度A型反应需专科治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Acute adverse drug reactions (ADR) to contrast agents have historically been divided in Type A (toxic/physiologic) reactions and Type B (hypersensitivity) reactions. Acute Type A adverse reactions are relatively uncommon after administration of iodine-based contrast media and gadolinium-based contrast agents, and rare after ultrasound contrast agents. Most acute Type A reactions are transient, mild, and of limited clinical consequence. Across all types of contrast agent (CA) classes, nausea and vomiting are the most frequently reported Type A reactions. In most cases, these reactions are caused by chemotoxicity and/or hyperosmolarity. Management of mild to moderate Type A reactions to contrast agents is often symptomatic and supportive, however, more severe Type A reactions need specialist treatment. We critically examined acute Type A ADR and nonspecific reactions following CA administration (labelled "physiologic" in the American College of Radiology classification) and propose a classification into three reaction types: acute non-hypersensitivity ADR, delayed Type A ADR, and Type B (hypersensitivity) ADR. This can facilitate accurate assessment and reporting of ADR to contrast agents.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. van der Molen AJ, Vega F. Acute non-hypersensitivity adverse reactions following intravascular administration of contrast agents in adult patients. Eur J Radiol. 2025. PMID: 40818215. doi:10.1016/j.ejrad.2025.112355

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。